lobbying_activities: 1124083

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1124083	9ad56e7c-4f41-47c2-b396-efbe5f2c3b36	Q2	AMYLIN PHARMACEUTICALS	308536	AMYLIN PHARMACEUTICALS	2011	second_quarter	PHA	Perscription Drug User Fee Act reauthorization FDA funding and agency effectiveness Drug importation issues	HOUSE OF REPRESENTATIVES,SENATE		230000	0	0	2011-07-19T16:09:54.103000-04:00